Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYTurning Point Therapeutics Presents Preclinical Data For Novel RET Inhibitor Candidate, TPX-0046PREV STORYNextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting